Home > Insider Trading > Filing (0001493152-25-006003)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1812727	Reliance Global Group Inc.	RELI	Insurance Agents, Brokers & Service (6411)	463390293

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1953618	Joel Markovits	C/O Reliance Global Group, Inc. 300 Blvd. Of The Americas, Suite 105 Lakewood NJ 08701	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-08-01	8	$3.60	10,828	No	4	F	Direct
Common Stock	Disposition	2024-09-04	9	$2.67	10,819	No	4	F	Direct
Common Stock	Disposition	2024-10-02	9	$2.36	10,810	No	4	F	Direct
Common Stock	Disposition	2024-11-01	10	$2.38	10,800	No	4	F	Direct
Common Stock	Disposition	2024-11-22	10,603	$1.37	197	No	4	S	Direct
Common Stock	Disposition	2024-12-02	12	$1.54	185	No	4	F	Direct
Common Stock	Disposition	2025-01-02	10	$2.89	175	No	4	F	Direct
Common Stock	Acquisiton	2025-01-21	185,221	$0.00	185,396	No	4	A	Direct
Common Stock	Disposition	2025-02-04	16,537	$1.96	168,859	No	4	F	Direct
Common Stock	Acquisiton	2025-02-05	49,000	$0.00	217,859	No	4	A	Direct
Common Stock	Disposition	2025-02-07	17,056	$1.88	200,803	No	4	F	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	F	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct
No	4	A	Direct
No	4	F	Direct

Footnotes

Represents the payment of tax liability by delivering securities incident to the receipt of a previously reported stock grant, which was issued in accordance with Rule 16b-3. This transaction is exempt from Section 16(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 37,045 shares on January 27, 2025; and (ii) with respect to 37,044 shares on each of February 3, 2025, July 15, 2025, July 30, 2025, and August 15, 2025.
Represents the payment of tax liability incident to the receipt of the January 21, 2025 stock grant, which was issued in accordance with Rule 16b-3 pursuant to the Exchange Act. This transaction is exempt from Section 16(b) of the Exchange Act.
Represents the grant of shares of common stock, approved by the compensation committee, comprised solely of independent directors, of the issuer's board of directors and issued in accordance with Rule 16b-3 promulgated under the Exchange Act. The grant vests (i) with respect to 16,334 shares on August 30, 2025; and (ii) with respect to 16,333 shares on each of September 15, 2025, and September 30, 2025.